Evidence brief · Supplement

Lutein & Zeaxanthin for Age-related macular degeneration

Evidence grade B — Slows progression

Overall grade
Grade B
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Age-related macular degenerationEvidence grade B

    Slows progression

    Unclearmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Studies disagree: Age-related macular degeneration (mixed agreement).

The evidence in words

The verdict

For age-related macular degeneration, Lutein & Zeaxanthin earns evidence grade B (unclear effect, mixed consistency) — there is real evidence here. Slows progression

How it might work

They form macular pigment that filters blue light and quenches oxidative stress in the retina.

How to use it

10 mg lutein + 2 mg zeaxanthin/day (the AREDS2 amounts), with fat.

Safety & cautions

Very safe.

Bottom line

Genuinely evidence-based for at-risk eyes (AREDS2). 10 mg lutein + 2 mg zeaxanthin with a meal.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
10 mg lutein + 2 mg zeaxanthin/day with fat.

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.